{"pmid":32314596,"title":"Challenges in Heart Transplantation in the Era of COVID-19.","text":["Challenges in Heart Transplantation in the Era of COVID-19.","Circulation","DeFilippis, Ersilia M","Farr, Maryjane A","Givertz, Michael M","32314596"],"journal":"Circulation","authors":["DeFilippis, Ersilia M","Farr, Maryjane A","Givertz, Michael M"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314596","week":"202017|Apr 20 - Apr 26","doi":"10.1161/CIRCULATIONAHA.120.047096","keywords":["covid-19","coronavirus","pandemic"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520113709057,"score":8.518259,"similar":[{"pmid":32266937,"title":"Inside the heart of COVID-19.","text":["Inside the heart of COVID-19.","Cardiovasc Res","Adao, Rui","Guzik, Tomasz J","32266937"],"journal":"Cardiovasc Res","authors":["Adao, Rui","Guzik, Tomasz J"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266937","week":"202015|Apr 06 - Apr 12","doi":"10.1093/cvr/cvaa086","keywords":["cardiovascular system","sars-cov-2","coronavirus","pandemic","angiotensin-converting enzyme 2"],"source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1664637636033118208,"score":51.13322},{"pmid":32253113,"pmcid":"PMC7141445","title":"COVID-19: Yet another coronavirus challenge in transplantation.","text":["COVID-19: Yet another coronavirus challenge in transplantation.","J Heart Lung Transplant","Aslam, Saima","Mehra, Mandeep R","32253113"],"journal":"J Heart Lung Transplant","authors":["Aslam, Saima","Mehra, Mandeep R"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32253113","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.healun.2020.03.007","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664640769741291520,"score":49.74436},{"pmid":32315732,"title":"Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America.","text":["Virtual Visits for Care of Patients with Heart Failure in the Era of COVID-19: A Statement from the Heart Failure Society of America.","J Card Fail","Gorodeski, Eiran Z","Goyal, Parag","Cox, Zachary L","Thibodeau, Jennifer T","Reay, Rebecca","Rasmusson, Kismet","Rogers, Joseph G","Starling, Randall C","32315732"],"journal":"J Card Fail","authors":["Gorodeski, Eiran Z","Goyal, Parag","Cox, Zachary L","Thibodeau, Jennifer T","Reay, Rebecca","Rasmusson, Kismet","Rogers, Joseph G","Starling, Randall C"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315732","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.cardfail.2020.04.008","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664714520213323776,"score":48.400833},{"pmid":32315122,"title":"COVID-19 in a High-Risk Dual Heart and Kidney Transplant Recipient.","text":["COVID-19 in a High-Risk Dual Heart and Kidney Transplant Recipient.","The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly infecting people worldwide, resulting in the infectious disease coronavirus disease 19 (COVID-19) that has been declared a pandemic. Much remains unknown about COVID-19, including its effects on solid organ transplant (SOT) recipients. Given their immunosuppressed state, SOT recipients are presumed to be at high risk of complications with viral infections such as SARS-CoV-2. Limited case reports in single SOT recipients, however, have not suggested a particularly severe course in this population. In this report, we present a dual-organ (heart/kidney) transplant recipient who was found to have COVID-19 and, despite the presence of a number of risk factors for poor outcomes, had a relatively mild clinical course.","Am J Transplant","Hsu, Jeffrey J","Gaynor, Pryce","Kamath, Megan","Fan, Ashley","Al-Saffar, Farah","Cruz, Daniel","Nsair, Ali","32315122"],"abstract":["The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is rapidly infecting people worldwide, resulting in the infectious disease coronavirus disease 19 (COVID-19) that has been declared a pandemic. Much remains unknown about COVID-19, including its effects on solid organ transplant (SOT) recipients. Given their immunosuppressed state, SOT recipients are presumed to be at high risk of complications with viral infections such as SARS-CoV-2. Limited case reports in single SOT recipients, however, have not suggested a particularly severe course in this population. In this report, we present a dual-organ (heart/kidney) transplant recipient who was found to have COVID-19 and, despite the presence of a number of risk factors for poor outcomes, had a relatively mild clinical course."],"journal":"Am J Transplant","authors":["Hsu, Jeffrey J","Gaynor, Pryce","Kamath, Megan","Fan, Ashley","Al-Saffar, Farah","Cruz, Daniel","Nsair, Ali"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315122","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ajt.15936","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664714520019337216,"score":45.332825},{"pmid":32286679,"title":"COVID-19 challenge for modern medicine.","text":["COVID-19 challenge for modern medicine.","Coronaviruses cause disease in animals and people around the world. Human coronaviruses (HCoV) are mainly known to cause infections of the upper and lower respiratory tract but the symptoms may also involve the nervous and digestive systems. Since the beginning of December 2019, there has been an epidemic of SARS-CoV-2, which was originally referred to as 2019-nCoV. The most common symptoms are fever and cough, fatigue, sputum production, dyspnea, myalgia, arthralgia or sore throat, headache, nausea, vomiting or diarrhea (30%). The best prevention is to avoid exposure. In addition, contact persons should be subjected to mandatory quarantine. COVID-19 patients should be treated in specialist centers. A significant number of patients with pneumonia require passive oxygen therapy. Non-invasive ventilation and high-flow nasal oxygen therapy can be applied in mild and moderate non-hypercapnia cases. A lung-saving ventilation strategy must be implemented in acute respiratory distress syndrome and mechanically ventilated patients. Extracorporeal membrane oxygenation is a highly specialized method, available only in selected centers and not applicable to a significant number of cases. Specific pharmacological treatment for COVID-19 is not currently available. Modern medicine is gearing up to fight the new coronavirus pandemic. The key is a holistic approach to the patient including, primarily, the use of personal protective equipment to reduce the risk of further virus transmission, as well as patient management, which consists in both quarantine and, in the absence of specific pharmacological therapy, symptomatic treatment.","Cardiol J","Dzieciatkowski, Tomasz","Szarpak, Lukasz","Filipiak, Krzysztof J","Jaguszewski, Milosz","Ladny, Jerzy R","Smereka, Jacek","32286679"],"abstract":["Coronaviruses cause disease in animals and people around the world. Human coronaviruses (HCoV) are mainly known to cause infections of the upper and lower respiratory tract but the symptoms may also involve the nervous and digestive systems. Since the beginning of December 2019, there has been an epidemic of SARS-CoV-2, which was originally referred to as 2019-nCoV. The most common symptoms are fever and cough, fatigue, sputum production, dyspnea, myalgia, arthralgia or sore throat, headache, nausea, vomiting or diarrhea (30%). The best prevention is to avoid exposure. In addition, contact persons should be subjected to mandatory quarantine. COVID-19 patients should be treated in specialist centers. A significant number of patients with pneumonia require passive oxygen therapy. Non-invasive ventilation and high-flow nasal oxygen therapy can be applied in mild and moderate non-hypercapnia cases. A lung-saving ventilation strategy must be implemented in acute respiratory distress syndrome and mechanically ventilated patients. Extracorporeal membrane oxygenation is a highly specialized method, available only in selected centers and not applicable to a significant number of cases. Specific pharmacological treatment for COVID-19 is not currently available. Modern medicine is gearing up to fight the new coronavirus pandemic. The key is a holistic approach to the patient including, primarily, the use of personal protective equipment to reduce the risk of further virus transmission, as well as patient management, which consists in both quarantine and, in the absence of specific pharmacological therapy, symptomatic treatment."],"journal":"Cardiol J","authors":["Dzieciatkowski, Tomasz","Szarpak, Lukasz","Filipiak, Krzysztof J","Jaguszewski, Milosz","Ladny, Jerzy R","Smereka, Jacek"],"date":"2020-04-15T11:00:00Z","year":2020,"_id":"32286679","week":"202016|Apr 13 - Apr 19","doi":"10.5603/CJ.a2020.0055","keywords":["covid-19","sars-cov-2","coronavirus","epidemiology","healthcare","medical stuff","pandemic","symptoms","treatment"],"source":"PubMed","topics":["Diagnosis","Prevention","Treatment"],"weight":1,"locations":["myalgia","arthralgia","headache","diarrhea"],"_version_":1664636391610384384,"score":43.94039}]}